Skip to main content

Table 3 Univariate and multivariate logistic regression analysis of IAC factors of pGGNs within 2 cm in a training cohort

From: Construction and validation of a predictive model of invasive adenocarcinoma in pure ground-glass nodules less than 2 cm in diameter

Variables

Univariate analysis

Multivariate analysis

OR (95%CI)

P value

OR (95%CI)

P value

Gender

  Female

Ref.

Ref.

Ref.

Ref.

  Male

1.615 (1.043, 2.499)

0.031

2.154 (0.859, 5.458)

0.103

Smoking history

  Non-smoker

Ref.

Ref.

Ref.

Ref.

  Smoker

1.697 (0.999, 2.856)

0.048

0.721 (0.304, 1.685)

0.453

Pleural effusion sign

  No

Ref.

Ref.

Ref.

Ref.

  Yes

2.779 (1.785, 4.344)

< 0.001

2.548 (1.398, 4.700)

0.002

Bronchus sign

  No

Ref.

Ref.

Ref.

Ref.

  Yes

4.103 (2.452, 6.935)

< 0.001

2.662 (1.286, 5.576)

0.009

Location

  Centrality

Ref.

Ref.

Ref.

Ref.

  Peripherality

0.415 (0.194, 0.884)

0.022

0.288 (0.104, 0.794)

0.016

Lobulation

  No

Ref.

Ref.

Ref.

Ref.

  Yes

2.760 (1.669, 4.575)

< 0.001

2.260 (1.078, 4.799)

0.032

Vascular penetration sign

  No

Ref.

Ref.

Ref.

Ref.

  Yes

2.372 (1.492, 3.846)

< 0.001

0.549 (0.275, 1.074)

0.083

Shape

  Regularity

Ref.

Ref.

Ref.

Ref.

  Irregularity

3.798 (2.436, 5.993)

< 0.001

1.559 (0.819, 2.962)

0.174

Spiculation

  No

Ref.

Ref.

Ref.

Ref.

   Yes

3.105 (2.001, 4.865)

< 0.001

1.288 (0.699, 2.360)

0.413

Blood type

  A

Ref.

Ref.

Ref.

Ref.

  B

1.550 (0.898, 2.698)

0.117

1.790 (0.875, 3.722)

0.114

  AB

2.009 (0.991, 4.055)

0.051

2.356 (0.898, 6.187)

0.08

  O

0.986 (0.541, 1.788)

0.964

0.757 (0.352, 1.609)

0.472

ASA

  1

Ref.

Ref.

Ref.

Ref.

  2

1.982 (1.020, 4.169)

0.054

0.425 (0.153, 1.222)

0.104

  3

4.091 (0.154, 109.087)

0.332

1.412 (0.045, 46.131)

0.828

  Maximum diameter

16.916 (8.943, 33.624)

< 0.001

11.130 (5.044, 25.966)

< 0.001

  Age

1.056 (1.033, 1.081)

< 0.001

1.054 (1.018, 1.094)

0.004

  SA

1.046 (1.013, 1.081)

0.006

1.050 (1.002, 1.100)

0.04

  PNI

1.063 (1.013, 1.120)

0.016

1.084 (1.002, 1.183)

0.054

  Erythrocyte

1.801 (1.130, 2.895)

0.014

2.196 (0.759, 6.471)

0.147

  Hemoglobin

1.015 (1.000, 1.030)

0.048

0.975 (0.941, 1.010)

0.157

  Cyfra21_1

1.438 (1.137, 1.846)

0.003

1.232 (0.911, 1.705)

0.186

  CEA

1.198 (1.017, 1.421)

0.032

1.099 (0.877, 1.366)

0.401

  Lymphocyte

1.445 (1.012, 2.068)

0.043

0.973 (0.527, 1.769)

0.929

Hypertension

 

  No

Ref.

Ref.

  

  Yes

1.372 (0.836, 2.227)

0.205

  

Diabetes

  No

Ref.

Ref.

  

  Yes

0.966 (0.471, 1.887)

0.922

  

COPD

  NO

Ref.

Ref.

  

  Yes

2.258 (0.268, 19.002)

0.418

  

Calcification

  No

Ref.

Ref.

  

  Yes

4818859.448 (0.000, NA)

0.98

  

Cavitation sign

  No

Ref.

Ref.

  

  Yes

1.181 (0.581, 2.307)

0.633

  

Pleural effusion sign

  No

Ref.

Ref.

  

  Yes

0

0.981

  

Lymph node enlargement sign

  No

Ref.

Ref.

  

  Yes

1.479 (0.715, 2.972)

0.278

  

AISI

1.000 (0.999, 1.001)

0.811

  

Albumin

1.037 (0.983, 1.099)

0.204

  

Basophil

4.812 (0.191, 336.295)

0.339

  

Blood sugar

1.064 (0.905, 1.248)

0.432

  

BMI

1.014 (0.947, 1.086)

0.681

  

CA125

1.010 (0.978, 1.042)

0.521

  

Complement C1q

1.000 (0.993, 1.007)

0.996

  

dNLR

0.845 (0.536, 1.309)

0.46

  

Eosinophil

1.588 (0.639, 4.419)

0.312

  

FEV1% predicted (%)

1.005 (0.992, 1.019)

0.438

  

IDH

1.000 (0.993, 1.006)

0.917

  

MLR

1.054 (0.558, 1.769)

0.83

  

Monocyte

1.205 (0.879, 1.952)

0.279

  

MVV% predicted (%)

1.001 (0.998, 1.005)

0.396

  

Neutrophil

1.077 (0.877, 1.317)

0.473

  

NLPR

0.003

0.813

  

NLR

0.923 (0.685, 1.226)

0.589

  

NSE

1.010 (0.975, 1.045)

0.572

  

PIV

1.000 (0.999, 1.001)

0.811

  

Platelet

1.000 (0.997, 1.004)

0.81

  

PLR

0.998 (0.994, 1.002)

0.41

  

Pro-GRP

0.997 (0.980, 1.011)

0.663

  

SCC

0.849 (0.583, 1.167)

0.361

  

SII

1.000 (0.999, 1.001)

0.465

  

SIRI

1.028 (0.836, 1.236)

0.748

  

5’-NT

1.004 (0.886, 1.121)

0.944

  
  1. IAC Invasive adenocarcinoma, COPD Chronic obstructive pulmonary diseases, ASA American Society of Anesthesiologists, PNI Prognostic nutritional index, NLR Neutrophil-lymphocyte ratio, PLR Platelet-lymphocyte ratio, MLR Monocyte-lymphocyte ratio, dNLR derived neutrophil-to-lymphocyte ratio, NLPR Neutrophil to lymphocyte and platelet ratio, SIRI Systemic inflammatory response syndrome, AISI Aggregate index of systemic inflammation, SII Systemic inflammation index, PIV Pan-immune-inflammation value, LDH, Lactate dehydrogenase, SA Serum amyloid, 5'-NT 5'-nucleotidase, Pro-GRP Pro-gastrin-releasing peptide, SCC Squamous cell carcinoma, Cyfra21-1 Cytokeratin 19-fragments, CEA Carcinoembryonic antigen, CA125 Carcinoma antigen 125, NSE Neuron-specific enolase, BMI Body mass index, FEV1 Forced expiratory volume in one second, MVV Maximal voluntary ventilation